BG48572A3 - Method for preparing of avermectines - Google Patents
Method for preparing of avermectinesInfo
- Publication number
- BG48572A3 BG48572A3 BG082655A BG8265588A BG48572A3 BG 48572 A3 BG48572 A3 BG 48572A3 BG 082655 A BG082655 A BG 082655A BG 8265588 A BG8265588 A BG 8265588A BG 48572 A3 BG48572 A3 BG 48572A3
- Authority
- BG
- Bulgaria
- Prior art keywords
- alkyl
- soon
- exhibit
- substituted
- halogen atoms
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 229940058299 avermectines Drugs 0.000 title 1
- 230000000694 effects Effects 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 241001468227 Streptomyces avermitilis Species 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- 125000000081 (C5-C8) cycloalkenyl group Chemical group 0.000 abstract 1
- 108010046716 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) Proteins 0.000 abstract 1
- 239000005660 Abamectin Substances 0.000 abstract 1
- 108010088278 Branched-chain-amino-acid transaminase Proteins 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 108090000340 Transaminases Proteins 0.000 abstract 1
- 102000003929 Transaminases Human genes 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 238000010564 aerobic fermentation Methods 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000006350 alkyl thio alkyl group Chemical group 0.000 abstract 1
- 239000003096 antiparasitic agent Substances 0.000 abstract 1
- 229940125687 antiparasitic agent Drugs 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000013521 mastic Substances 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
- C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US651287A | 1987-01-23 | 1987-01-23 | |
US10782587A | 1987-10-13 | 1987-10-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
BG48572A3 true BG48572A3 (en) | 1991-03-15 |
Family
ID=26675723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG082655A BG48572A3 (en) | 1987-01-23 | 1988-01-18 | Method for preparing of avermectines |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0284176B1 (xx) |
JP (1) | JPH0817694B2 (xx) |
KR (1) | KR900007937B1 (xx) |
CN (1) | CN1065277C (xx) |
AP (1) | AP53A (xx) |
AR (1) | AR244344A1 (xx) |
AU (1) | AU636709B2 (xx) |
BG (1) | BG48572A3 (xx) |
CA (1) | CA1338141C (xx) |
CZ (1) | CZ290312B6 (xx) |
DE (1) | DE3883408T2 (xx) |
DK (1) | DK175724B1 (xx) |
EG (1) | EG18796A (xx) |
ES (1) | ES2058244T3 (xx) |
FI (1) | FI90087C (xx) |
HU (1) | HU203130B (xx) |
IE (1) | IE62467B1 (xx) |
IL (1) | IL85119A (xx) |
MA (1) | MA21161A1 (xx) |
MX (1) | MX169293B (xx) |
MY (1) | MY102581A (xx) |
NO (2) | NO172446C (xx) |
NZ (1) | NZ223270A (xx) |
PT (1) | PT86582B (xx) |
RU (1) | RU2096462C1 (xx) |
YU (2) | YU47877B (xx) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0313297B1 (en) * | 1987-10-23 | 1993-05-19 | Pfizer Inc. | Process for production of avermectin aglycones and cultures therefor |
GB8807280D0 (en) * | 1988-03-26 | 1988-04-27 | Pfizer Ltd | Antiparasitic agents |
GB8809232D0 (en) * | 1988-04-19 | 1988-05-25 | Pfizer Ltd | Antiparasitic agents |
GB8811036D0 (en) * | 1988-05-10 | 1988-06-15 | Glaxo Group Ltd | Chemical compounds |
US5030622A (en) * | 1989-06-02 | 1991-07-09 | Merck & Co., Inc. | Avermectin derivatives |
US5057499A (en) * | 1989-06-02 | 1991-10-15 | Merck & Co. Inc. | Avermectin derivatives |
NZ238521A (en) * | 1990-06-22 | 1992-12-23 | Merck & Co Inc | Process for the conversion of avermectin glycone to avermectin mono- and disaccharides by fermentation with streptomyces avermitilis ma6078 |
NZ240128A (en) * | 1990-10-15 | 1994-01-26 | Merck & Co Inc | Production of 13-beta and 5-beta ivermectin monoglucopyranosides from |
US5250422A (en) * | 1990-10-15 | 1993-10-05 | Merck & Co., Inc. | Biotransformation process for the production of invermectin derivatives |
US6103504A (en) * | 1992-03-25 | 2000-08-15 | Pfizer Inc. | Process for production of avermectins and cultures therefor |
US5292647A (en) * | 1992-11-30 | 1994-03-08 | Eli Lilly And Company | Strain of streptomyces for producing avermectins and processes therewith |
CN1038330C (zh) * | 1993-07-05 | 1998-05-13 | 塞泰克斯公司 | 阿弗麦菌素的生产与分离 |
EP0711349B1 (en) * | 1993-07-30 | 2003-09-03 | Pfizer Inc. | Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
US5466102A (en) | 1993-12-16 | 1995-11-14 | Kennametal Inc. | System for coupling machine tools |
GB9716567D0 (en) * | 1997-08-05 | 1997-10-08 | Pfizer | Process |
GB9825402D0 (en) | 1998-11-19 | 1999-01-13 | Pfizer Ltd | Antiparasitic formulations |
ES2365993T5 (es) | 2001-09-17 | 2020-06-25 | Elanco Us Inc | Formulaciones pesticidas |
CN101560535B (zh) * | 2009-05-26 | 2012-05-23 | 浙江升华拜克生物股份有限公司 | 一种基于代谢参数our补糖发酵生产阿维菌素工艺 |
EP2490697A1 (en) | 2009-10-19 | 2012-08-29 | Intervet International B.V. | Method and formulation for the control of parasites |
RU2454420C1 (ru) * | 2011-03-31 | 2012-06-27 | Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" | Цитотоксические полусинтетические производные макролидного антибиотика олигомицина а и способ их получения |
CN104877925B (zh) * | 2014-02-28 | 2018-05-25 | 中国科学院沈阳应用生态研究所 | 一种异壁放线菌和三种新的抗真菌maclafungins类化合物及其制备和应用 |
CN116602242B (zh) * | 2023-05-08 | 2024-01-23 | 中国水产科学研究院珠江水产研究所 | 一种提高反季鱼苗成活率的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE434277B (sv) * | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
US4429042A (en) * | 1978-09-08 | 1984-01-31 | Merck & Co., Inc. | Strain of Streptomyces for producing antiparasitic compounds |
NZ204074A (en) * | 1982-05-10 | 1986-05-09 | Merck & Co Inc | Synergistic compositions containing avermectins |
NZ207655A (en) * | 1983-04-07 | 1986-09-10 | Merck & Co Inc | Synergistic veterinary compositions containing an avermectin compound and clorsulon |
NZ210505A (en) * | 1983-12-22 | 1988-06-30 | Merck & Co Inc | Parasiticidal compositions containing avermectin or milbemycin derivatives |
US4579864A (en) * | 1984-06-11 | 1986-04-01 | Merck & Co., Inc. | Avermectin and milbemycin 13-keto, 13-imino and 13-amino derivatives |
ES8800986A1 (es) * | 1985-07-27 | 1987-12-01 | Pfizer | Un procedimiento para la produccion de un nuevo derivado de avermectina |
GB8606120D0 (en) * | 1986-03-12 | 1986-04-16 | Glaxo Group Ltd | Process |
EP0240274A3 (en) * | 1986-04-03 | 1990-03-14 | Merck & Co. Inc. | Avermectins as growth promotant agents |
-
1988
- 1988-01-18 ES ES88300353T patent/ES2058244T3/es not_active Expired - Lifetime
- 1988-01-18 IL IL85119A patent/IL85119A/xx not_active IP Right Cessation
- 1988-01-18 BG BG082655A patent/BG48572A3/xx unknown
- 1988-01-18 EP EP88300353A patent/EP0284176B1/en not_active Expired - Lifetime
- 1988-01-18 DE DE88300353T patent/DE3883408T2/de not_active Expired - Lifetime
- 1988-01-19 MA MA21398A patent/MA21161A1/fr unknown
- 1988-01-21 CA CA000556996A patent/CA1338141C/en not_active Expired - Fee Related
- 1988-01-21 YU YU10988A patent/YU47877B/sh unknown
- 1988-01-21 CZ CS1988408A patent/CZ290312B6/cs unknown
- 1988-01-21 PT PT86582A patent/PT86582B/pt unknown
- 1988-01-22 IE IE15988A patent/IE62467B1/en not_active IP Right Cessation
- 1988-01-22 NO NO880261A patent/NO172446C/no not_active IP Right Cessation
- 1988-01-22 KR KR1019880000469A patent/KR900007937B1/ko not_active IP Right Cessation
- 1988-01-22 DK DK198800286A patent/DK175724B1/da not_active IP Right Cessation
- 1988-01-22 NO NO880262A patent/NO172447C/no not_active IP Right Cessation
- 1988-01-22 NZ NZ223270A patent/NZ223270A/en unknown
- 1988-01-22 JP JP63012461A patent/JPH0817694B2/ja not_active Expired - Lifetime
- 1988-01-22 FI FI880279A patent/FI90087C/fi not_active IP Right Cessation
- 1988-01-22 MX MX026651A patent/MX169293B/es unknown
- 1988-01-22 CN CN88100373A patent/CN1065277C/zh not_active Expired - Lifetime
- 1988-01-22 RU SU884355097A patent/RU2096462C1/ru active
- 1988-01-22 AR AR88309889A patent/AR244344A1/es active
- 1988-01-22 AP APAP/P/1988/000077A patent/AP53A/en active
- 1988-01-22 HU HU88259A patent/HU203130B/hu unknown
- 1988-01-25 MY MYPI88000058A patent/MY102581A/en unknown
- 1988-02-21 EG EG3488A patent/EG18796A/xx active
-
1990
- 1990-05-21 YU YU99090A patent/YU47886B/sh unknown
-
1991
- 1991-02-15 AU AU71113/91A patent/AU636709B2/en not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG48572A3 (en) | Method for preparing of avermectines | |
BG51051A3 (en) | Process for production of b avermektins | |
ES8203421A1 (es) | Un procedimiento para la preparacion de acido griseolico | |
UA19162A (uk) | Спосіб одержаhhя аhтибіотика s541, штами стрептоміцетів - продуцеhти аhтибіотика s541 | |
CA2212326A1 (en) | O-carbamoyl-(d)-phenylalanilol compounds and process for preparing the same | |
MY105067A (en) | Process for the preparation of 7-substituted-hept-6-enoic and -heptanoic acids and derivatives and intermediates thereof. | |
AU1739092A (en) | 1-methylcarbapenem derivatives, their preparation and their use as antibiotics | |
AU6572896A (en) | Enantiomerically enriched thiazolidine or oxazolidine compounds | |
AT379800B (de) | Verfahren zur herstellung von neuen 2-oxazetidin-derivaten | |
GB1472667A (en) | Nucleosidic antibiotic and derivatives thereof | |
EP0249938A3 (en) | Imidazolesulfonamide derivatives,herbicides and a method for inhibiting growth of undesirable plants | |
AU579869B2 (en) | 4-amino-8-alkylthio-2-piperazino-pyrimido ``5,4-d`` pyrimidines | |
IE860840L (en) | Enantioselective process for producing¹i-beta-methylcarbapenem antiobiotic intermediates | |
HUT40614A (en) | Process for production of derivatives of amin-akryl-acid | |
ES8604960A1 (es) | Procedimiento para preparar derivados de 1,6-naftiridina | |
HUT46945A (en) | Process for producing new azoxy derivatives and pharmaceutical compositions containing them as active components | |
HU9300283D0 (en) | Method for producing amino-benzoic acid derivatives and pharmaceutical preparatives containing them | |
HU9300080D0 (en) | Method for producing unsaturated acids and their esters | |
BG51252A3 (en) | Method for netylmycin preparation | |
ATE34176T1 (de) | 2'-chloropentostatin, eine diese verbindung enthaltende pharmazeutische zusammensetzung und ein mikroorganismus zur herstellung dieser verbindung. | |
DD210709A1 (de) | Verfahren zur herstellung des antibiotikums a51568 mit den faktoren a und b | |
CA1273347C (xx) | ||
ES8104242A1 (es) | Un procedimiento para la preparacion de nuevos derivados de hidantoina. | |
GB1387769A (en) | Butenoic acid derivatives and a process for the manufacture thereof | |
DE3480792D1 (de) | 2-amino-1,9-dihydro-6h-purin-6-one-7-oxyde, die pharmazeutisch vertraeglichen salze und ein verfahren zu ihrer herstellung. |